CDK7 and breast carcinoma: While the effects of CDK7 inhibitors on breast cancer are not yet fully understood, CDK7 is known to play a dual role in cell cycle progression and transcription initiation by phosphorylating RNA polymerase II and priming cell cycle CDKs for activation, making it an attractive therapeutic target162.